Robarge, Mike,Harrington, John,Gerrish, David,Mecom, John
申请号：
AU2013364022
公开号：
AU2013364022A1
申请日:
2013.12.23
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are benzazepine compounds. These compounds are serotonin receptor (5-HT2c) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT2c) is desired (e.g. addiction, anxiety, depression, obesity, and others).
